---
title: 'Vice President, Market Access (Hybrid/Remote) at Ceribell, Inc'
canonical: 'https://feeny.ai/job/vice-president-market-access-hybrid-remote-ceribell-inc-sunnyvale-6hbrjy6ppr87'
type: 'job'
last_seen: '2026-11-09'
---

# Vice President, Market Access (Hybrid/Remote) at Ceribell, Inc

- **Company:** Ceribell, Inc
- **Location:** Sunnyvale, CA
- **Compensation:** $280k–$320k
- **Work type:** hybrid
- **Posted:** 2026-11-05
- **Last confirmed live:** 2026-11-09
- **Apply:** https://job-boards.greenhouse.io/ceribell/jobs/6238600004

## Job description

## About Ceribell

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting, and is being used in hundreds of community hospitals, large academic facilities and major IDN's across the country. Our entire team is driven by a shared commitment to transforming the landscape of critical care through our rapid seizure detection technology, come join the movement!

The Vice President of Market Access will own Ceribell’s reimbursement, payer, and health policy strategy to accelerate adoption of our neuro-diagnostic solutions. As a member of the commercial leadership team, this leader is accountable for the coverage, payment, and policy outcomes that enable growth, and serves as the company’s senior authority on reimbursement and health policy.

This role builds and leads the Market Access organization, including strategy, policy, evidence, health economic tooling, and field reimbursement. The VP partners with the CEO, CFO, Chief Revenue Officer, and other executive leaders to ensure the value of Ceribell’s technology is clearly understood by payers, policymakers, and health system leaders.

## What you'll achieve

Lead the Market Access organization

- Build, lead, and develop a team spanning HEOR, payer and policy strategy, and  health economic tools.
- Own headcount planning, budget, and vendor and consultant strategy
- Set functional goals, MBOs, and operating cadence

Own payment and access strategy and external relationships

- Own the multi-year payment and access roadmap for Ceribell’s portfolio, including POC EEG and emerging neuromonitoring technologies
- Lead strategy for new and existing payment pathways, including MS-DRG and add-on payment mechanisms, and pursue coding and coverage pathways (e.g., CPT/HCPCS, payer medical policy) where they support adoption
- Anticipate and mitigate payment risk, not only pursue upside
- Identify and resolve barriers across payment, hospital workflows, and provider economics in ED, ICU, and inpatient settings
- Cultivate senior relationships with MAC medical directors, national and regional commercial payers, Medicaid plans, IDNs, CMS staff, and health system CFOs
- Oversee payer and health system education initiatives that highlight Ceribell’s clinical evidence, economic value, and outcomes impact
- Represent Ceribell as a thought leader at industry, payer, and policy forums

Drive federal policy and regulatory strategy

- Own CMS rulemaking strategy (IPPS, OPPS, PFS, NTAP, and TCET pathways), including comment letters and public testimony
- Engage CMS, Congress, and policymakers on Breakthrough Device payment policy
- Manage relationships with trade associations, coalitions, specialty societies (e.g., AdvaMed, neurology and critical care societies), and outside counsel and consultants

Set evidence and health economic strategy

- Set the evidence generation strategy and prioritize investment across HEOR, real-world evidence, and publications to support payer, hospital, and policy goals
- Co-own the evidence plan with the CMO and Medical Affairs
- Oversee budget impact models and cost-effectiveness analyses that clearly articulate Ceribell’s clinical and financial impact

Lead health economic tooling

- Own the strategy, development, and governance of health economic tools, including economic impact calculators, budget impact models, and program cost comparisons for payers, hospitals, and health systems
- Ensure tools are built on validated, defensible assumptions and are tailored to different hospital types and care settings
- Equip sales leadership and field teams with these tools, along with the training and guidance to use them effectively with hospital C-suite and finance buyers
- Keep tools current as payment policy and evidence evolve

Partner with Commercial

-

- Set the standard for how economic and reimbursement value is communicated to payers and health system leaders
- Support strategic IDN and health system engagements where access and economics intersect
- Quantify and report the impact of access wins and risks to the executive team and Board
- Other responsibilities as assigned by your Manager/Supervisor

What We're Looking For:

- Bachelor’s degree in health policy, business, science, public health, or a related field; MBA, MPH, MHA, or JD preferred
- 15+ years of experience in the medical device, diagnostics, or digital health industry, with 8+ years directly in market access, reimbursement, HEOR, or health policy
- 5+ years leading and developing teams, including managers or directors, ideally including a field-based reimbursement or customer reimbursement support team
- Led a successful payment pathway end to end (e.g., NTAP, MS-DRG assignment, new CPT code, or national coverage), ideally for a novel or Breakthrough-designated technology
- Deep expertise in U.S. reimbursement, particularly inpatient: DRG payment, CMS policy and rule making, NTAP/TCET, commercial payer processes, and medical policy development; working knowledge of CPT/HCPCS
- Experience building or overseeing health economic models and tools used by commercial teams
- Experience building compliant field reimbursement programs and partnering closely with sales leadership
- Experience advising C-suite and Board and representing the company externally with CMS and policymakers
- Strong analytical skills and the ability to translate complex clinical and economic evidence into persuasive payer and executive messaging
- Experience in high-growth or public-company environments preferred

## Compensation Range

$280,000—$320,000 USD

A candidate’s final salary offer will be based on their skills, education, work location and experience, and thus it may differ from the posted range. Compensation may also include bonuses consistent with Ceribell’s corporate compensation plan. Note, the above description is not all-encompassing and Ceribell reserves the right to change or modify job duties and assignments at any time.

In addition to your base compensation, Ceribell offers eligible employees the following:

- Performance-based incentive compensation (varies by role)
- Equity opportunities
- 100% Employer paid Health Benefits for Employees
- 50% - 70% Employer paid Health, Dental & Vision for dependents (depending on plan selection)
- 100% paid Life and Long-Term Disability Insurance
- 401(k) with a generous company match
- Employee Stock Purchase Plan (ESPP) with a discount
- Monthly cell phone stipend
- Flexible paid time off
- 13 Paid Holidays + 3 Company Wellness Days
- Excellent parental leave policy
- Fantastic culture with tremendous career advancement opportunities
- Joining a mission-minded organization!

Application Deadline: Ongoing

Other Job Details Ceribell reports transfers of value to health care providers (HCPs) as required by federal and state transparency laws. These laws and implementing regulations require Ceribell to provide government agencies with HCPs’ names, addresses and the type of payments or other value received, generally for public disclosure. If you are an HCP and we pay or reimburse your recruiting expenses as a result of interviewing with Ceribell, your name, address and the amount of payments made may be reported to the government.

## Equal Opportunity Employer

Ceribell is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex (including pregnancy, childbirth and related medical conditions), sexual orientation, gender identity or expression, national origin, age, marital status, disability, veteran status or any other characteristic protected by law. Ceribell complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Ceribell is an E-Verify employer. Any applicant with a disability who requires an accommodation during the application process should contact talent@ceribell.com to request reasonable accommodation.

Privacy Statement For information on how Ceribell processes personal data of job applicants, please review our[Privacy Policy](https://ceribell.com/privacy-policy/).

Compliance Disclaimer If you believe this job posting is non-compliant, please submit a report to legal@ceribell.com. Please note that we will not respond to inquiries unrelated to job posting compliance.

## About Ceribell, Inc

## Company Overview
- **One-liner**: Ceribell is a medical technology company that has developed an AI-powered, point-of-care electroencephalography (EEG) platform to rapidly diagnose and continuously monitor patients with suspected seizures in acute care settings.
- **Entity Type**: Public (NASDAQ: CBLL, IPO October 2024)
- **Headquarters**: Sunnyvale, California, United States
- **Founded**: 2014 (incorporated as Brain Stethoscope, Inc., renamed CeriBell, Inc. in 2015)
- **Founders**: Not publicly listed on the company website or primary SEC filings; the company was founded by a team of medical device and neurology experts.

## Core Business
- **Primary Industry**: Medical Equipment Manufacturing / Healthcare Technology
- **Target Customers**: B2B — specifically hospitals, intensive care units (ICUs), and emergency departments (EDs) in the acute care setting.
- **Mission Statement**: To make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions. The company’s stated goal is to establish the Ceribell System as the standard of care for EEG in the acute care setting.

## Products & Services
- **[Ceribell System]**: A novel, point-of-care EEG platform combining proprietary, highly portable and rapidly deployable hardware with sophisticated AI-powered algorithms. It enables rapid diagnosis and continuous monitoring of patients with neurological conditions, specifically for detecting suspected seizure activity. The system is FDA 510(k) cleared and has received multiple FDA Breakthrough Designations. It is designed to be used in ICUs and emergency rooms, allowing clinicians to test for a suspected seizure and deliver treatments within minutes.

## Market Standing
- **Valuation/Market Cap**: Not publicly available in the search results; as a recent IPO, market cap fluctuates.
- **Key Metric (Revenue)**: **$89.1 million** annual revenue (as of latest available data).
- **Key Metric (Funding)**: Total funding of **$171 million** prior to IPO, including a Series A ($13M, 2017), Series B ($35M, 2018), and Series C ($103M across two rounds in 2021 and 2022).
- **Key Metric (Cash Position)**: As of September 30, 2025, the company held **$168.5 million** in cash, cash equivalents, and marketable securities. The company had an accumulated deficit of $206.8 million as of that date [sec.gov](https://www.sec.gov/Archives/edgar/data/1861107/000119312525264882/R9.htm).
- **Notable Investors**: The Rise Fund, Ally Bridge Group, Longitude Capital, Optimas Capital Partners, Horizon Technology Finance.
- **Growth Signals**:
    - Headcount grew **20% year-over-year**, reaching 295 employees [linkedin.com](https://www.linkedin.com/company/ceribell).
    - The company has **45 peer-reviewed publications** supporting its technology [ceribell.com](https://ceribell.com/).
    - Holds **FedRAMP High cybersecurity authorization** [ceribell.com](https://ceribell.com/).
    - Active job postings have grown **11.4% year-over-year** [linkedin.com](https://www.linkedin.com/company/ceribell).
    - The company has a presence in the US, Canada, and China, and utilizes contract manufacturers in China and Vietnam.

## Competitive Advantages
- **First-Mover & Regulatory Moat**: The Ceribell System is the first FDA 510(k) cleared point-of-care EEG for detecting electrographic status epilepticus, with multiple FDA Breakthrough Designations. This creates a significant regulatory and clinical validation barrier for competitors.
- **AI-Powered Speed**: The system is designed for speed ("time is brain"), enabling diagnosis and treatment in minutes rather than the hours or days required by traditional EEG setups.
- **Clinical Evidence**: 95% sensitivity and 97% specificity for detecting seizures, supported by 45 peer-reviewed publications demonstrating reduced length of ICU stay, decreased hospital transfers, and better patient outcomes [ceribell.com](https://ceribell.com/).
- **Portability & Ease of Use**: The system is designed to be highly portable and rapidly deployable, unlike traditional EEG machines which are bulky and require specialized technicians to set up.

## Strategic Focus
- **Standard of Care**: The company's primary strategic focus is to establish the Ceribell System as the *standard of care* for EEG in the acute care setting across the U.S.
- **Commercial Expansion**: Continued expansion of its sales force (the largest department at 32% of headcount) into new hospital systems and territories.
- **Product Development**: Ongoing R&D investment in AI, data engineering, and hardware to enhance the platform's capabilities and expand its clinical indications.
- **Financial Path to Profitability**: As a recently public company with an accumulated deficit, a key strategic focus is managing cash burn ($168.5M in cash) while growing revenue to achieve profitability.

## Why Work Here
- **Meaningful Impact**: Employees directly contribute to a technology that saves lives and improves outcomes for patients with serious neurological conditions. The company describes its work as "disruptive patient care" [ceribell.com](https://ceribell.com/about-us/culture-careers/).
- **Growth Trajectory**: As a recent IPO with 20% headcount growth, the company offers significant career growth opportunities. The careers page explicitly states, "At Ceribell, your contributions matter" and highlights "influencing the trajectory of our growth" [ceribell.com](https://ceribell.com/about-us/culture-careers/).
- **Professional Development**: The company offers comprehensive sales training programs, mentorship opportunities, and is launching leadership and professional development initiatives [ceribell.com](https://ceribell.com/about-us/culture-careers/).
- **Work Policy**: Hybrid and remote roles are available. Job postings include "Hybrid" (e.g., Sunnyvale HQ roles) and "Remote" (e.g., AI & Data Systems Engineer, Director of Data Engineering) positions [greenhouse.io](http://job-boards.greenhouse.io/ceribell).
- **Culture**: Described as "action-oriented" and "fast-paced," with a focus on "fostering inclusion" and celebrating wins together. The company emphasizes a "vibrant and diverse team" [ceribell.com](https://ceribell.com/about-us/culture-careers/).
- **Employee Sentiment Note**: On LinkedIn, the employer rating is 2.6/5.0 (64 reviews), with Culture rated lowest at 2.4 and Compensation rated highest at 3.1. This suggests potential challenges with work-life balance or internal culture that candidates should investigate during interviews [linkedin.com](https://www.linkedin.com/company/ceribell).

## Sources
1. [ceribell.com](https://ceribell.com/)
2. [ceribell.com](https://ceribell.com/about-us/culture-careers/)
3. [linkedin.com](https://www.linkedin.com/company/ceribell)
4. [greenhouse.io](http://job-boards.greenhouse.io/ceribell)
5. [sec.gov](https://www.sec.gov/Archives/edgar/data/1861107/000119312525264882/R9.htm)

## Other roles at Ceribell, Inc

- [Vice President, Strategic Finance & Analytics (Hybrid)](https://feeny.ai/job/vice-president-strategic-finance-analytics-hybrid-ceribell-inc-sunnyvale-c3p7e1p985sz) — Sunnyvale, CA
- [Clinical Account Manager- South Bay//Peninsula](https://feeny.ai/job/clinical-account-manager-south-bay-peninsula-ceribell-inc-south-bay-sng66rr9572s) — South Bay, CA
- [Manager, Strategic Clinical Research](https://feeny.ai/job/manager-strategic-clinical-research-ceribell-inc-sunnyvale-0103qd1jpx74) — Sunnyvale, CA
- [Territory Manager - Minnesota](https://feeny.ai/job/territory-manager-minnesota-ceribell-inc-minneapolis-3ewwq0j6p9h1) — Minneapolis, MN
- [Associate Director of Sales Strategy & Operations](https://feeny.ai/job/associate-director-of-sales-strategy-operations-ceribell-inc-sunnyvale-10e0b7y97tt6) — Sunnyvale, CA
- [Territory Manager - Houston](https://feeny.ai/job/territory-manager-houston-ceribell-inc-houston-q3pyntqreyap) — Houston, TX
- [Clinical Account Manager- Queens](https://feeny.ai/job/clinical-account-manager-queens-ceribell-inc-long-island-wq26700wk5ph) — Long Island, NY
- [Clinical Account Manager- Long Island/Queens](https://feeny.ai/job/clinical-account-manager-long-island-queens-ceribell-inc-queens-029x8cxnpz09) — Queens, NY
- [Director, Research & Data](https://feeny.ai/job/director-research-data-ceribell-inc-sunnyvale-hnhs39rn1c3f) — Sunnyvale, CA
- [Associate Director, Sales Enablement (Hybrid)](https://feeny.ai/job/associate-director-sales-enablement-hybrid-ceribell-inc-sunnyvale-yr6jsztwag5s) — Sunnyvale, CA